PATIENT PREFERENCE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT INHALERS- A DISCRETE CHOICE EXPERIMENT (DCE) IN FRANCE

Author(s)

Chouaid C1, Germain N2, de Pouvourville G3, Aballea S4, Korchagina D2, Baldwin M5, Le Lay K6, Luciani L6, Devillier P7, Toumi M8
1Centre Hospitalier Intercommunal, DHU-ATVB, Département de Pneumologie et Pathologie Professionnelle, Créteil, France, 2Creativ Ceutical, Paris, France, 3ESSEC Business School, Cergy-Pontoise, France, 4Creativ Ceutical, Rotterdam, The Netherlands, 5Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, 6Boehringer-Ingeleheim France, Paris, France, 7UPRES EA220, Hôpital Foch, Suresnes, France, 8Aix-Marseille University, Marseille, France

OBJECTIVES: Patients’ preference is increasingly explored for COPD treatments, notably because poor inhaler adherence is a major challenge. Understanding inhaler preferences may contribute to adherence and improve long-term outcomes. This study aimed to identify and quantify preferences for convenience-related inhaler attributes in French moderate-to-severe COPD patients, with DCE methodology. No previous studies report on these characteristics in this population.

METHODS: Attributes were defined from a literature search, expert- and patient interviews. An online DCE with COPD patients aged 40-75, using an inhaler for COPD was conducted, including a 2-phase pilot study and cognitive-debriefing interviews. The choice scenarios presented fictitious inhalers with 7 attributes; shape, dose insertion, dose preparation, dose release, dose confirmation, dose counter, and reusability. The COPD Assessment Test and 18 questions on diagnosis, treatment and socio-demographics were included. A D-efficient design with priors was used. Analyses used a mixed logit regression model with random effects. 3 inhaler profiles were of particular interest: Inhaler A - soft mist inhaler, Inhaler B - single dose dry powder inhaler Inhaler C – multi-dose dry powder inhaler.

RESULTS: CONCLUSIONS: The results show that a number of convenience-related inhaler characteristics are strong drivers of COPD patient preference in France and should be taken into account by clinicians prescribing these devices.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PMD181

Topic

Patient-Centered Research

Topic Subcategory

Stated Preference & Patient Satisfaction

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×